StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
AGL

agilon health, inc.

AGL NYSE Services-Misc Health & Allied Services, NEC EDGAR ↗
$94.11
+2.50 +2.73%

Key statistics

from XBRL data in SEC filings
Market cap
$1.57B
Revenue (TTM)
$5.82B
Net income (TTM)
-$355M
EPS (TTM)
P/E ratio
Dividend yield
Free cash flow
-$119M
Cash
$140M
Total assets
$1.50B
Gross margin
52-week range
$7.48 – $133.04

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change Jul 22, 2026 8-K Shareholder vote results Jun 3, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Director or officer change; Regulation FD disclosure Apr 27, 2026 8-K Modified rights of security holders; Amended charter or bylaws Mar 30, 2026 8-K Shareholder vote results; Other events Mar 18, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 25, 2026 8-K Entered a material agreement; Took on a direct financial obligation Feb 12, 2026 8-K Director or officer change Jan 7, 2026 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Nov 7, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 4, 2025 10-Q Quarter ended 2025-06-30 Aug 4, 2025 8-K Results of operations (earnings release); Director or officer change; Amended charter or bylaws; Regulation FD disclosure Aug 4, 2025 8-K Shareholder vote results May 30, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 6, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 25, 2025 8-K Entered a material agreement; Other events Dec 5, 2024 8-K Regulation FD disclosure Nov 19, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Director or officer change; Regulation FD disclosure Jun 5, 2024 8-K Shareholder vote results Jun 3, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 10-K Fiscal year ended 2023-12-31 Feb 27, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 27, 2024 8-K Director or officer change Feb 8, 2024 8-K Director or officer change; Regulation FD disclosure Jan 5, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 5, 2024 8-K Regulation FD disclosure Nov 14, 2023 10-Q Quarter ended 2023-09-30 Nov 2, 2023 8-K Results of operations (earnings release) Nov 2, 2023 8-K Director or officer change Aug 16, 2023